Please use this identifier to cite or link to this item:
Type of publication: Straipsnis Clarivate Analytics Web of Science ar/ir Scopus / Article in Clarivate Analytics Web of Science or / and Scopus (S1)
Field of Science: Teisė / Law (S001)
Author(s): Grigienė, Jurgita;Čerka, Paulius;Perkumienė, Dalia
Title: Can a parallel importer rebrand pharmaceutical products in the EU?
Is part of: Baltic journal of European studies. Warsaw : De Gruyter Poland, 2019, vol. 9, iss. 1
Extent: p. 57-76
Date: 2019
Keywords: Parallel import;Rebranding;Repacking;Trade mark
Abstract: The European Union has established the free movement of goods, which covers the parallel import of goods in the EU. However, the free movement of goods should not infringe on the rights of trade mark owners. In some cases, parallel importer needs not only to repackage but also to rebrand pharmaceutical products. ECJ has stated that rebranding is permissible if objective necessity to rebrand exists. But it is the national court that has to determine what objective necessity is. This paper analyses the decisions of EU Member States. In some cases, objective necessity has been determined on similar grounds. However, in other cases, a necessity to enter some part of the market has been evaluated differently in different Member States. The different evaluation of the necessity criterion could be treated as the infringement of uniform application of the free movement of goods in the EU
Affiliation(s): Privatinės teisės katedra
Teisės fakultetas
Vytauto Didžiojo universitetas
Appears in Collections:Universiteto mokslo publikacijos / University Research Publications

Files in This Item:
marc.xml6.99 kBXMLView/Open

MARC21 XML metadata

Show full item record
Export via OAI-PMH Interface in XML Formats
Export to Other Non-XML Formats

Page view(s)

checked on Aug 17, 2019

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.